Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo

Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo

Yellow fever virus (YFV) infection is a major public concern that threatens a large population in South America and Africa. No specific anti-YFV drugs are available till now. Here, we report that rifapentine is a potent YFV inhibitor in various cell lines by high-throughput drugs screening, acting a...

Full description

Bibliographic Details
Main Authors: Xijing Qian, Bingan Wu, Hailin Tang, Zhenghan Luo, Zhenghao Xu, Songying Ouyang, Xiangliang Li, Jianfeng Xie, Zhigang Yi, Qibin Leng, Yan Liu, Zhongtian Qi, Ping Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Emerging Microbes and Infections
Subjects:
Yellow fever virus
antiviral agents
rifamycin antibiotics
viral entry
viral replication
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2022.2049983

Internet

https://www.tandfonline.com/doi/10.1080/22221751.2022.2049983

Similar Items